Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAMPP: Amoxicillin for Mild Pediatric Pneumonia
NCT05726253Phase 1Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in community acquired pneumonia (CAP) comparing Amoxicillin with Placebo (2 arms). Primary endpoint: Enrollment Rate Per Month at 6 months. Started Jan 2023; status: completed.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT05726253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726253.